Pneumococcal disease is a significant cause of morbidity and mortality in the United States. Streptococcus pneumoniae accounts for 20% to 60% of all community-acquired bacterial pneumonias (CAP) in adults. The risks for complications, hospitalizations, and death from pneumococcus pneumonia are higher among persons aged >65 years. The pneumococcal vaccine protects against the Streptococcus pneumoniae.
Disclaimer: Measures reported by WCHQ healthcare
organizations represent a specific aspect of care in relation to an
evidence-based standard, but are not clinical guidelines and do not establish
standards of care.
This measure assesses the percentage of adults greater than or equal to 65 years who had a pneumococcal vaccination.